Steven A. Lee-Kong, MD, FASCRS
Steven Lee-Kong, MD, Assistant Professor of Surgery, is trained in all aspects of colon and rectal surgery. With a special interest in minimally invasive surgery, he introduced robotic colorectal surgery to NewYork-Presbyterian and routinely uses the technique for a variety of different conditions. He is responsible for evaluating and adopting new technologies for use in the Colorectal Surgery Division.
Dr. Lee-Kong is also highly trained in advanced surgery for inflammatory bowel disease, which includes ulcerative colitis and Crohn’s disease. He has performed a high volume of surgeries on patients with Crohn’s disease, many of whom require removal of the colon, rectum, or anus.
Dr. Lee-Kong completed almost all of his medical and surgical education at NYP/Columbia, including his medical degree in 2004 and residency in general surgery (2004 to 2011. He completed a research fellowship in colorectal surgery at Memorial Sloan-Kettering Cancer Center from 2007-2009, where he studied rectal cancer and hypoxia and early-age-of-onset colorectal cancer. After completing general surgery residency, he completed a colon and rectal surgery fellowship at a joint program between Weill Cornell Medical College and Memorial Sloan-Kettering.
Lee-Kong SA, Lisle D. Surgical management of complicated colon cancer. Clin Colon Rectal Surg. 2015;28(4):228-233.
Lee-Kong SA, Kiran RP. Ongoing challenges and controversies in ulcerative colitis surgery. Expert Rev Gastroenterol Hepatol. 2015 Dec 16:1-5. [Epub ahead of print]
Pasam RT, Murray AC, Lee-Kong SA, Kiran RP. The minimally invasive approach is associated with reduced surgical site infections in obese patients undergoing proctectomy. Tech Coloproctol. 2015;19(12):733-743.
Esemuede IO, Murray AC, Lee-Kong SA, Feingold DL, Kiran RP. Obesity, Regardless of Comorbidity, Influences Outcomes After Colorectal Surgery – Time to Rethink the Pay-for-Performance Metrics? J Gastrointest Surg. 2014;18:2163-2168.
O’Donoghue JA, Guillem JG, Schoder H, Lee NY, Divgi CR, Ruby JA, Humm JL, Lee-Kong SA, Burnazi EM, Shangde C, Carlin SD, Leibold T, Zanzonico PB, Ling CC. Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal and head and neck cancer. EJNMMI Research. 2013;3:42